Becton Dickinson (BDX) – Press Releases
-
Revelyst Announces Chief Supply Chain Officer
-
BD Named a Best Employer for Excellence in Employee Well-Being
-
BD Increases Access to Cutting-Edge Image-Enabled, Spectral Cell Sorters
-
BD to Announce Financial Results for its Second Quarter of Fiscal 2024
-
New Survey Reveals Patients Receive Too Many Needlesticks
-
BD Named Among Fortune's Most Innovative Companies
-
BD Increases Domestic Production to Support U.S. Health Care Need for Syringes
-
BD and Health Care Consortium in Denmark Find Success in Medical Waste Recycling Study
-
Zeus Names New Chief Executive Officer
-
New Study Highlights Benefits of Medication Management Automation in Long-Term Care Facilities
-
BD Initiates International Study to Expand Treatment Options for Patients with Peripheral Arterial Disease
-
Dave Hickey Announces Intent to Retire from BD
-
BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore
-
BD to Present at Investor Healthcare Conferences
-
BD to Present Next Installment of BD Innovates Series: Spotlight on Peripheral Vascular Disease
-
BD Reports First Quarter Fiscal 2024 Financial Results
-
BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing
-
BD Helps Advance Health Equity for Women in Kenya through Critical Cancer Screening
-
BD Board Declares Dividend
-
BD, Hamilton Collaborate to Standardize Single-Cell Multiomics Experiments Using Robotics
-
New Survey by The Harris Poll Highlights Gaps in Cervical Cancer Screening Access
-
BD Announces Webcast of Annual Meeting of Shareholders
-
BD to Announce Financial Results for its First Quarter of Fiscal 2024
-
BD to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
BD Signs World Economic Forum's Zero Health Gaps Pledge
-
BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
-
BD to Present Next Installment of BD Innovates Series: Spotlight on Pharmaceutical Systems
-
FDA Safety Communication Does Not Impact BD Syringes
-
BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency
-
BD Names Dr. Ronald Silverman as Chief Medical Officer
-
BD to Present at the 6th Annual Evercore ISI HealthCONx Conference
-
BD Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results
-
BD Board Increases Dividend for 52nd Consecutive Year
-
KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer
-
BD Advances "One-Stick Hospital Stay" Vision with Launch of Next-Generation Needle-Free Blood Draw Technology
-
BD Named Among the 100 Best Corporate Citizens of 2023
-
BD Names Greg Rodetis as Senior Vice President of Investor Relations
-
BD, Casella Complete Industry-First Pilot Recycling 40,000 Pounds of Used Medical Devices
-
BD, Casella Complete Industry-First Pilot Recycling 40,000 Pounds of Used Medical Devices
-
BD to Announce Fiscal 2023 Fourth Quarter and Full Year Financial Results
-
Azenta Announces CFO Transition
-
BD Ranks in Top 10 for Transparency, Awarded Best Code of Conduct in 2023 U.S. Transparency Awards
-
Nation’s Top 10 Most Transparent Companies Unveiled in Labrador’s 2023 U.S. Transparency Awards
-
Navigate BioPharma Services, Inc. Announces Collaboration with BD (Becton, Dickinson and Company) to Advance Capabilities for Clinical Phases of Drug Development
-
BD to Present at Investor Healthcare Conferences
-
BD Reports Third Quarter Fiscal 2023 Financial Results
-
STERIS Completes the Acquisition of Surgical Instrumentation Assets from BD
-
STERIS Announces Financial Results for Fiscal 2024 First Quarter
-
BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
-
BD Board Declares Dividend
Back to BDX Stock Lookup
